A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 3,300 shares of CSBR stock, worth $13,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,300
Previous 2,600 26.92%
Holding current value
$13,134
Previous $12,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.5 - $5.23 $11,731 - $13,634
-2,607 Reduced 20.33%
10,218 $52,000
Q1 2024

May 15, 2024

SELL
$4.9 - $6.91 $8,829 - $12,451
-1,802 Reduced 12.32%
12,825 $62,000
Q4 2023

Feb 14, 2024

BUY
$4.56 - $6.59 $16,849 - $24,350
3,695 Added 33.8%
14,627 $82,000
Q3 2023

Nov 14, 2023

SELL
$5.2 - $7.32 $23,311 - $32,815
-4,483 Reduced 29.08%
10,932 $67,000
Q2 2023

Aug 14, 2023

BUY
$4.11 - $6.81 $12,046 - $19,960
2,931 Added 23.48%
15,415 $98,000
Q1 2023

May 15, 2023

SELL
$4.0 - $4.67 $102,132 - $119,239
-25,533 Reduced 67.16%
12,484 $50,000
Q4 2022

Feb 14, 2023

BUY
$3.75 - $7.69 $2,640 - $5,413
704 Added 1.89%
38,017 $171,000
Q3 2022

Nov 14, 2022

BUY
$7.21 - $9.47 $149,362 - $196,180
20,716 Added 124.82%
37,313 $280,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $53.8M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.